Gene Editing in Cancer Immunotherapy: Mechanisms, Advancements, Limitations and Future Directions

References (36)

1. 1 CRISPR-engineered T cells in patients with refractory cancer [DOI]
2. 2 Engineering CAR-T Cells for Next-Generation Cancer Therapy [DOI]
3. 3 CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy [DOI]
4. 4 Origins and evolution of CRISPR-Cas systems [DOI]
5. 5 Current applications and future perspective of CRISPR/Cas9 gene editing in cancer [DOI]
6. 6 CRISPR-Cas9 DNA Base-Editing and Prime-Editing [DOI]
7. 7 MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy [DOI]
8. 8 Gene Therapy for Cancer Treatment: Past, Present and Future [DOI]
9. 9 Mechanisms of Cancer Resistance to Immunotherapy [DOI]
10. 10 A Review on the Mechanism and Applications of CRISPR/Cas9/Cas12/Cas13/Cas14 Proteins Utilized for Genome Engineering [DOI]
11. 11 CRISPR technologies for genome, epigenome and transcriptome editing [DOI]
12. 12 Epigenome editing technologies for discovery and medicine [DOI]
13. 13 Mechanisms of tumor resistance to immune checkpoint blockade and combination strategies to overcome resistance [DOI]
14. 14 The interaction of intestinal microbiota and innate lymphoid cells in health and disease throughout life [DOI]
15. 15 Efficient Gene Editing at Major CFTR Mutation Loci [DOI]
16. 16 CRISPR/Cas9 Genome Editing for Tissue‐Specific In Vivo Targeting: Nanomaterials and Translational Perspective [DOI]
17. 17 Precision RNA base editing with engineered and endogenous effectors [DOI]
18. 18 Delivery of CRISPR/Cas9 system by AAV as vectors for gene therapy [DOI]
19. 19 CRISPR/Cas9 in Cancer Immunotherapy: Animal Models and Human Clinical Trials [DOI]
20. 20 CRISPR Craze to Transform Cardiac Biology [DOI]
21. 21 Genome Editing in Engineered T Cells for Cancer Immunotherapy [DOI]
22. 22 Calponin 3 suppresses proliferation, migration and invasion of non‑small cell lung cancer cells [DOI]
23. 23 Clinical trials and promising preclinical applications of CRISPR/Cas gene editing [DOI]
24. 24 An Overview of Tools for Genome Editing: ZFNs, Mega Nucleases, and TALENs [DOI]
25. 25 Current Advances and Material Innovations in the Search for Novel Treatments of Phenylketonuria [DOI]
26. 26 The CRISPR-Cas System and Clinical Applications of CRISPR-Based Gene Editing in Hematology with a Focus on Inherited Germline Predisposition to Hematologic Malignancies [DOI]
27. 27 Emerging Gene-editing nano-therapeutics for Cancer [DOI]
28. 28 In vivo application of base and prime editing to treat inherited retinal diseases [DOI]
29. 29 Therapeutic potential of CRISPR/CAS9 genome modification in T cell-based immunotherapy of cancer [DOI]
30. 30 Zinc Finger Nuclease (ZFNs) and Transcription Activator-like Effector Nucleases (TALENs) Based Genome Editing in Enhancement of Anticancer Activity of Plants [DOI]
31. 31 Clinical gene therapy development for the central nervous system: Candidates and challenges for AAVs [DOI]
32. 32 Transcription Activator-Like Effector Nucleases (TALENs): Genome Editing Tool to Explore Enhanced Activity of Antidiabetic Plants [DOI]
33. 33 Allogeneic Chimeric Antigen Receptor T Cells: A Further Potential Weapon for Haematological Malignancies [DOI]
34. 34 Science [DOI]
35. 35 ALLO-647 for Lymphodepletion in the Allogeneic CAR T Setting: Safety Experience with ALLO-501/501A in Patients (Pts) with Relapsed/Refractory (r/r) Large B-Cell and Follicular Lymphomas [DOI]
36. 36 CRISPR-Cas12/Cas13: bibliometric analysis and systematic review of its application in infectious diseasedetection [DOI]

Cited by 7

Showing 4 of 7 known citations — external sources report more than can currently be individually listed.

Related research

• Does Pain Adversely Affect the Quality of Life in Hospitalized Cancer Patients? — shares topic coverage
• Complementary Medicine Intervention in Breast Cancer Patients with Pain — shares topic coverage
• Use of Performance Status Score for Cytotoxic Chemotherapy among Surgeons in a Tertiary Hospital, Southern Nigeria — shares topic coverage
• Breast Self Examination and Cancer Awareness among Female Staff in Federal Medical Center, Yenagoa, Bayelsa State (Knowledge and Practice) — shares topic coverage
• Assessment of Cancer Risk from Fluorscopic Bile Duct Examinations at Sanjiwani Hospital, Gianyar — shares topic coverage